Andrew Serafini Fenwick & West LLP
Results 1 to 1 of 1
IP provisions and ROI for state-funded stem cell-based products and technologies in California *
USA - May 31 2012
The California Institute of Regenerative Medicine (CIRM) reaches the end of its initial charter in 2017 and recently published its Transition Plan.
Co-authors: Gene Yee.
Co-authors of Andrew Serafini
Other Fenwick & West LLP authors
- Barry Kramer,
- Dan Ko Obuhanych,
- Daniel Brownstone,
- Daniel J. McCoy,
- David Austin,
- David Tellekson,
- Ewa M. Davison,
- Heather N. Mewes,
- Jedediah Wakefield,
- Matt Rossiter,
- Michael A. Sands,
- Michael J. Patrick,
- Michael J. Shuster,
- Michael T. Esquivel,
- Michelle Lee,,
- Pauline Farmer-Koppenol,
- Robert R. Sachs,
- Saundra L. M. Riley,
- Sean Wikner,
- Stuart P. Meyer